As of Jul 25
| -0.03 / -0.05%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 65.00, with a high estimate of 68.00 and a low estimate of 55.00. The median estimate represents a +10.75% increase from the last price of 58.69.
The current consensus among 4 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.